Equities New York Outlook: Only moderate gains after recovery rally | 12/08/21

NEW YORK (dpa-AFX) – After the recent recovery rally, investors on the US stock exchanges should take it easy for the time being in the middle of the week. Around three quarters of an hour before the start of trading, the broker IG assessed the leading index Dow Jones Industrial (Dow Jones 30 Industrial) 0.21 percent higher to 35,794 points and the technology-heavy NASDAQ 100 0.05 percent up to 16,334 points.

Statements by the pharmaceutical giant Pfizer and its Mainz partner Biontech (BioNTech (ADRs)) proved to be a support for the course. Accordingly, the common corona vaccine against the new coronavirus variant Omikron is less effective than against previous variants. With three doses – i.e. after a vaccination booster – a similar neutralizing effect was shown, as with two doses with the original type of the virus.

While the Pfizer stocks themselves then gained more than one percent before the IPO and are likely to build on their previous day’s recovery, the shares of Biontech listed in New York even went up by a good three and a half percent. Shares of the Biontech competitor Moderna gained about half a percent before the market.

For the shares of the online broker Robinhood, a further price recovery of a good two and a half percent became apparent after they had slipped to the lowest level in the company’s stock market history, which was just over four months old, on Monday./gl/mis


Trade forex with high leverage and small spreads. With only € 100.00 you can benefit from the effect of € 3,000 in capital.

72% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford the high risk of losing your money.


Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.